Tweet
I am new to the field of metagenomics, can you please recommend me the minimum requirements of a desktop to carry out the analysis. Such as QIIME and other tools.
Thanks,
Thanks,
-
-
Depends on what kind of metagenomics you are carrying out, whole genome or 16S? -
its 16s
not the whole genome,Comment
-
With 16S I'd recommend firstly looking at an alignment tool, the alignment tool can be the hardest one to figure out. There are alot and they all have their benefits.
QIIME has (close to) all the needed tools for 16S in it. If, and i mean IF, you can install it on your pc it's worth it.Comment
-
yah, thanks for the information
I need to provide the minimum system requirements for my work to proceed.
Thanking you,Comment
-
Any computer will do. Of course, if you don't want to wait for days/months/weeks/years, a faster one will do better. I've been running 16S stuff with QIIME on 15" rMBP (quadcore 2.7GHz i7, 16 GB RAM) and found that in general analyses will not take longer than a day (everybody in our bioinfo team has this laptop). Of course sample size and the exact steps you take affect this enormously. For other things, I use a cluster with 352 physical cores and ~10 TB RAM. Even on it, some stuff can easily run for many days..Originally posted by rahbz View Postsavetherhino.orgComment
-
Proteomics platforms are evolving rapidly, with advances in mass spectrometry and affinity-based approaches expanding what researchers can detect and at what scale. As the field moves toward deeper proteome coverage and clinical applications, scientists face an increasingly complex landscape of tools. This article will explore how researchers are navigating these choices to find the right platform for their work.
The systematic characterization of the human proteome has...07-20-2026, 11:48 AM -
Genomics studies in neuroscience face a special challenge due to the brain’s complexity and scarcity of samples. Mapping changes in cell type and state using conventional next-generation sequencing methods remains challenging. Advances in technologies like single-cell sequencing, spatial transcriptomics, and long-read sequencing have opened the door to deeper studies of the brain and diseases like Alzheimer’s, amyotrophic lateral sclerosis (ALS), and schizophrenia.
...07-09-2026, 11:10 AM -
Cancer survival rates have significantly increased in the last few decades in the United States, reaching a combined 70% 5-year survival rate by 2021. Behind this number, there are years of research to find new therapies, drug targets, and early detection methods. But there is one core challenge that keeps slowing down these advances, and it’s about drug resistance.
There is no single reason why many patients don’t respond to treatment as expected. Cancer is...07-08-2026, 05:17 AM
Comment